Autologous blood vessels engineered from peripheral blood sample.

OBJECTIVE Although many efforts have been made to generate small-diameter (< or =5mm) vascular grafts by means of tissue engineering, improvement in patency and functionality still remains a great challenge. It is our hypothesis that to achieve long-term functionality and patency, not only the complete lining with endothelial cells but also full biocompatibility is essential. DESIGN The aim was the development of a conduit from a scaffold and endothelial progenitor cells (EPC) separated from peripheral blood of a single donor. MATERIALS AND METHODS EPC and a fibrin preparation were separated from porcine peripheral blood. Fibrin segments were generated seeded with EPC and were perfused in a bioreactor in vitro. RESULTS From 100ml blood 12-15 cm long fibrin tubes were successfully generated lined with endothelial-like cells. Seeded tubes showed a remarkable elasticity and burst strength up to 90 mm mercury. CONCLUSIONS Stable fibrin tubes were successfully generated completely lined with an endothelium-like monolayer from fibrin and EPC, both isolated from the same volume of blood. Although their stability is not those needed for arterial grafting, our results raise the hope, that with distinct improvements in future studies functional autologous vascular grafts could be engineered from the patient's own blood.

[1]  C. Perka,et al.  Matrix engineering for osteogenic differentiation of rabbit periosteal cells using alpha-tricalcium phosphate particles in a three-dimensional fibrin culture. , 2002, Journal of biomedical materials research.

[2]  N. Caplice,et al.  Smooth Muscle Progenitor Cells in Human Blood , 2002, Circulation.

[3]  H. Mertsching,et al.  Tissue-engineered bioprosthetic venous valve: a long-term study in sheep. , 2003, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[4]  B. McNeil,et al.  Use of cardiac procedures and outcomes in elderly patients with myocardial infarction in the United States and Canada. , 1997, The New England journal of medicine.

[5]  D. Mooradian,et al.  Manipulation of remodeling pathways to enhance the mechanical properties of a tissue engineered blood vessel. , 2002, Journal of biomechanical engineering.

[6]  J. H. van Bockel,et al.  Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting: five-year results of a randomized controlled trial. , 2003, Journal of vascular surgery.

[7]  T. Matsuda,et al.  Canine endothelial progenitor cell-lined hybrid vascular graft with nonthrombogenic potential. , 2003, The Journal of thoracic and cardiovascular surgery.

[8]  M. Boyer,et al.  Isolation of endothelial cells and their progenitor cells from human peripheral blood. , 2000, Journal of vascular surgery.

[9]  F. W. Blaisdell,et al.  Why small caliber vascular grafts fail: a review of clinical and experimental experience and the significance of the interaction of blood at the interface. , 1986, The Journal of surgical research.

[10]  Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI) , 2002 .

[11]  Anthony Atala,et al.  Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo , 2001, Nature Medicine.

[12]  Axel Haverich,et al.  Tissue engineering of small diameter vascular grafts. , 2002, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[13]  J. Cohn,et al.  Selection of saphenous vein conduit in varicose vein disease. , 2006, The Annals of thoracic surgery.

[14]  O. Wendler,et al.  Expression and function of laminins in the embryonic and mature vasculature. , 2005, Physiological reviews.

[15]  H. Augustin,et al.  Blood vessel maturation in a 3‐dimensional spheroidal coculture model: direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  K. Fujikawa,et al.  Alpha(1)-proteinase inhibitor, alpha(1)-antichymotrypsin, or alpha(2)-macroglobulin is required for vascular smooth muscle cell spreading in three-dimensional fibrin gel. , 2000, The Journal of biological chemistry.

[17]  U. V. von Oppell,et al.  In vitro endothelialization of expanded polytetrafluoroethylene grafts: a clinical case report after 41 months of implantation. , 1997, Journal of vascular surgery.

[18]  S Jockenhoevel,et al.  Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[19]  Narutoshi Hibino,et al.  Successful application of tissue engineered vascular autografts: clinical experience. , 2003, Biomaterials.

[20]  A Haverich,et al.  Use of a fibrin preparation in the engineering of a vascular graft model. , 2004, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[21]  James A. Russell,et al.  Engineering of fibrin-based functional and implantable small-diameter blood vessels. , 2005 .

[22]  R Langer,et al.  Functional arteries grown in vitro. , 1999, Science.

[23]  C K Breuer,et al.  Tissue engineering lamb heart valve leaflets , 1996, Biotechnology and bioengineering.

[24]  Yasuhide Nakayama,et al.  In Vivo Tissue-Engineered Small-Caliber Arterial Graft Prosthesis Consisting of Autologous Tissue (Biotube) , 2004, Cell transplantation.

[25]  R T Tranquillo,et al.  Enhanced fibrin remodeling in vitro with TGF-beta1, insulin and plasmin for improved tissue-equivalents. , 2002, Biomaterials.

[26]  Anthony Atala,et al.  Controlled fabrication of a biological vascular substitute. , 2006, Biomaterials.

[27]  Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration , 2003 .

[28]  P. Zilla,et al.  Clinical autologous in vitro endothelialization of 153 infrainguinal ePTFE grafts. , 2001, The Annals of thoracic surgery.

[29]  M G Walker,et al.  Tissue engineering of blood vessels , 2006, The British journal of surgery.

[30]  B J Messmer,et al.  Fibrin gel -- advantages of a new scaffold in cardiovascular tissue engineering. , 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[31]  C David Naylor,et al.  A randomized comparison of radial-artery and saphenous-vein coronary bypass grafts. , 2004, The New England journal of medicine.

[32]  J. Isner,et al.  Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[33]  H. Mertsching,et al.  Acellular Scaffold Implantation – No Alternative to Tissue Engineering , 2003, The International journal of artificial organs.

[34]  C. Verfaillie,et al.  Origin of endothelial progenitors in human postnatal bone marrow. , 2002, The Journal of clinical investigation.

[35]  Q. Yao,et al.  Differentiation and proliferation of endothelial progenitor cells from canine peripheral blood mononuclear cells. , 2005, The Journal of surgical research.

[36]  M. Sittinger,et al.  Preparation of a pure autologous biodegradable fibrin matrix for tissue engineering , 2000, Medical and Biological Engineering and Computing.

[37]  Julie H. Campbell,et al.  Advances in vascular tissue engineering. , 2003, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[38]  J. Vacanti,et al.  Tissue engineering : Frontiers in biotechnology , 1993 .

[39]  James T. Willerson,et al.  Transdifferentiation of Human Peripheral Blood CD34+-Enriched Cell Population Into Cardiomyocytes, Endothelial Cells, and Smooth Muscle Cells In Vivo , 2003, Circulation.

[40]  R. Vile,et al.  Diverse Origin and Function of Cells With Endothelial Phenotype Obtained From Adult Human Blood , 2003, Circulation research.